Best Practices for Successful Reentry From Criminal Justice Settings for People Living With Mental Health Conditions and/or Substance Use Disorders This guide examines the types of interventions that support successful reentry for adults with mental health conditions and/or substance use disorders who are leaving jail/prison.
May 2023 This month, the Surgeon General released two new advisories. Our Epidemic of Loneliness and Isolation focuses on the powerful effects of social connection on our health. Social Media and Youth Mental Health examines the current evidence on the impacts of social media on the mental health of children and adolescents, and steps needed to ensure social […]
From MedPage Today All Opioid Pain Meds to Get New Safety Warnings, FDA Says — Updated labeling to include warning about opioid-induced hyperalgesia The FDA is making several updates to the prescribing information for opioid pain medications to provide guidance on safe use, according to a Drug Safety Communicationopens in a new tab or window, […]
HHS Press Release
From the FDA February 28, 2023 FDA Takes Action to Restrict Unlawful Import of Xylazine Agency Aims to Maintain Availability for Legitimate Use in Animals while Preventing Importation for Illicit Purposes Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage […]
2023 2022 2021 Mental Health Awareness Month [NAMI] #MHAM #NotAlone Mental Health Month [MHA] #mhm2021 #Tools2Thrive
From Reuters U.S. FDA panel to review Emergent’s OTC opioid overdose drug Jan 10 (Reuters) – The U.S. health regulator said on Tuesday its advisory panel will meet on Feb. 15 to review Emergent Biosolutions Inc’s (EBS.N) over-the-counter (OTC) nasal spray to treat suspected opioid overdoses. Emergent is seeking the Food and Drug Administration’s (FDA)approval for the […]